CLX The Clorox Company
Consumer Defensive$96.23+1.18%ClosedMarket Cap: $11.64B
As of 2026-05-26
Valuation
P/E (TTM)
17.01
PEG
0.26
P/B
-172.28
P/S
1.70
EV/EBITDA
11.29
DCF Value
$277.22
FCF Yield
3.3%
Div Yield
5.2%
Margins & Returns
Gross Margin
43.8%
Operating Margin
15.7%
Net Margin
11.2%
ROE
2826.2%
ROA
11.7%
ROIC
16.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $1.67B | 43.2% | $284.0M | $187.0M | $— | $1.24 |
| Q2 null | $1.67B | 43.2% | $236.0M | $157.0M | $— | $1.24 |
| Q1 null | $1.43B | 41.7% | $120.0M | $80.0M | $— | $1.24 |
| Q4 null | $1.99B | 46.5% | $420.0M | $332.0M | $— | $1.22 |
| FY null | $7.10B | 45.2% | $1.18B | $810.0M | $— | $4.88 |
| Q3 null | $1.67B | 44.6% | $238.0M | $186.0M | $— | $1.22 |
| Q2 null | $1.69B | 43.8% | $231.0M | $193.0M | $— | $1.22 |
| Q1 null | $1.76B | 45.8% | $288.0M | $99.0M | $— | $1.22 |
| Q4 null | $1.90B | 46.5% | $288.0M | $216.0M | $— | $1.20 |
| FY null | $7.09B | 43.0% | $723.0M | $280.0M | $— | $4.80 |
| Q3 null | $1.81B | 42.0% | $218.0M | $-51.0M | $— | $1.20 |
| Q2 2024 | $1.99B | 43.2% | $322.0M | $93.0M | $0.75 | $1.20 |